David Wechsler*, Jed Lusthaus

*Corresponding author for this work

    Research output: Contribution to Newspaper/Magazine/WebsiteArticle


    • Primary open-angle glaucoma, the most common form, is asymptomatic until late in the course of disease, and irreversible vision loss can occur silently. • Screening tests are imperfect and there is a need to stratify individuals according to risk. • There are different risk factors, symptoms, signs and treatment of acute angle closure versus chronic open-angle glaucomas. • Current therapies are aimed at reducing the intraocular pressure (IOP), and medical management is the mainstay. • Glaucoma therapies have the potential for adverse effects both locally and systemically and for systemic interactions with other drugs. • There is a spectrum of severity and some patients are at risk of severe visual loss. These cases need to be identified and more aggressively managed, often requiring surgery to control the IOP.

    Original languageEnglish
    Number of pages8
    Specialist publicationAustralian Doctor
    PublisherReed Business Information
    Publication statusPublished - 8 Jul 2011


    Dive into the research topics of 'Glaucoma'. Together they form a unique fingerprint.

    Cite this